Clinical pharmacology of recombinant human follicle-stimulating hormone. III. Pharmacokinetic-pharmacodynamic modeling after repeated subcutaneous administration
- 1 April 1994
- journal article
- Published by Elsevier BV in Fertility and Sterility
- Vol. 61 (4), 687-695
- https://doi.org/10.1016/s0015-0282(16)56646-1
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Immunoreactive inhibin levels during ovarian stimulation may predict granulosa cell maturityClinical Endocrinology, 1992
- Prediction of response to controlled ovarian hyperstimulation: a comparison of basal and clomiphene citrate-stimulated follicle-stimulating hormone levelsFertility and Sterility, 1992
- Age related changes in follicle stimulating hormone, luteinizing hormone, oestradiol and immunoreactive inhibin in women of reproductive ageClinical Endocrinology, 1992
- Polycystic ovarian syndrome: safety and effectiveness of stepwise and low-dose administration of purified follicle-stimulating hormoneFertility and Sterility, 1991
- Low dose follicle-stimulating hormone therapy for polycystic ovarian diseaseFertility and Sterility, 1991
- Ovarian hyporesponsiveness in combined gonadotropin-releasing hormone agonist and menotropin therapy is associated with low serum follicle-stimulating hormone levelsFertility and Sterility, 1991
- A comparative, randomized study of low-dose human menopausal gonadotropin and follicle-stimulating hormone in women with polycystic ovarian syndromeFertility and Sterility, 1991
- Immunoreactive Inhibinα-Subunit in Human Serum: Implications for Radioimmunoassay*Journal of Clinical Endocrinology & Metabolism, 1990
- Inhibin and Estradiol Responses to Ovarian Hyperstimultion: Effects of Age and Predictive Value forin VitroFertilization OutcomeJournal of Clinical Endocrinology & Metabolism, 1990
- Understanding the Dose-Effect RelationshipClinical Pharmacokinetics, 1981